Literature DB >> 15207250

High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.

Todd R Parody1, Martin J Stone.   

Abstract

The specificity of leukocyte trafficking in inflammation is controlled by the interactions of chemokines with chemokine receptors. Reliable structure-function studies of chemokine-receptor interactions would benefit from cell lines that express consistent high levels of chemokine receptors. We describe herein two new Chinese hamster ovary (CHO) cell lines in which the genes for chemokine receptors CCR2 and CCR3 have been incorporated into identical positions in the host genome. CCR2 is the primary receptor for the chemokine monocyte chemoattractant protein-1 (MCP-1) whereas CCR3 is the primary receptor for the chemokines eotaxin-1, eotaxin-2 and eotaxin-3. Both receptors are expressed at >5,000,000 copies per cell, substantially higher levels than in previous cell lines, and both are competent for binding and activation by the cognate chemokines for these receptors. Using these cell lines we confirm that eotaxin-1 and eotaxin-3 can act as an agonist and an antagonist, respectively, of CCR2. In addition, we show that eotaxin-2 is an antagonist of CCR2 and MCP-1 is an agonist of CCR3. Comparison of the chemokine sequences reveals several positions that are identical in MCP-1 and eotaxin-1 but different in eotaxin-2 and eotaxin-3, suggesting that these amino acids play a role in CCR2 activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207250     DOI: 10.1016/j.cyto.2004.03.013

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

Authors:  C Günther; G Wozel; M Meurer; C Pfeiffer
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Meritxell Canals; Justin P Ludeman; Jamie Wedderburn; Christopher Boston; Stephen J Butler; Ann Marie Carrick; Todd R Parody; Deni Taleski; Arthur Christopoulos; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 4.  Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses.

Authors:  Ram Prasad Bhusal; Simon R Foster; Martin J Stone
Journal:  Protein Sci       Date:  2019-10-24       Impact factor: 6.725

5.  Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1.

Authors:  Samantha J Allen; Sofia Ribeiro; Richard Horuk; Tracy M Handel
Journal:  Protein Expr Purif       Date:  2009-03-09       Impact factor: 1.650

Review 6.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

Review 7.  CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.

Authors:  Jan Korbecki; Klaudyna Kojder; Donata Simińska; Romuald Bohatyrewicz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

Review 8.  The roles of CC chemokines in response to radiation.

Authors:  Lei Wang; Jizong Jiang; Yuan Chen; Qingzhu Jia; Qian Chu
Journal:  Radiat Oncol       Date:  2022-04-01       Impact factor: 3.481

9.  Pro-Inflammatory Chemokines CCL5, CXCL12, and CX3CL1 Bind to and Activate Platelet Integrin αIIbβ3 in an Allosteric Manner.

Authors:  Yoko K Takada; Masaaki Fujita; Yoshikazu Takada
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.